Tamtam Try Tamtam free
Agfa logo

Agfa account plan

Innovative Imaging IT Solutions

At a glance

Agfa-Gevaert is a Belgian imaging-technology group in healthcare IT, film and green hydrogen membranes: FY2025 revenue 1,086 million euro, 4,211 employees.

Agfa-Gevaert, headquartered in Mortsel, Belgium, develops, manufactures and sells analog and digital imaging systems for hospitals and imaging networks, the printing industry, the green hydrogen industry and industrial applications. It has production and research centres in Belgium, the United States, Canada, the United Kingdom, Austria and China, and sales organisations in more than 30 countries. FY2025 revenue was 1,086 million euro (-4.5%), adjusted EBITDA 59 million euro and the net result -71 million euro; it had 4,211 employees, 69% of them in Europe. It is listed (market capitalisation 78 million euro at 31 December 2025), its largest disclosed shareholder is Active Ownership Capital (15-20%), and since Q3 2026 its continuing operations are two segments, HealthCare IT and Imaging and Advanced Materials, with Digital Printing Solutions being combined with EFI.

Business units

Strategic priorities

Cloud and SaaS transition in HealthCare IT
Move Enterprise Imaging to the cloud and win share in North America; 12-month cloud order intake more than tripled to 90.7 million euro by Q3 2026. Management sees 2028 as the pivot year and EBITDA margins of 20-25% once the business is mainly cloud/SaaS.
Shrink the film cost base
A self-funding programme (internally Moonshot, the restructuring of Mortsel operations) targets 50 million euro of savings by end-2027; annualised savings reached 64 million euro by Q3 2026 and production headcount was almost halved.
Green hydrogen with ZIRFON
ZIRFON membranes are described as a core pillar of the growth strategy; a new plant opened in September 2025, and after a weak 2026 the company expects a significant upturn in 2027 driven by projects that reached FID and demand in China and India.
Liquidity first
The CEO called liquidity the first priority while the next couple of years remain transformation years; the 180 million euro RCF was extended to 1 August 2030 and a receivables factoring programme was started with BNP Paribas Fortis.
Portfolio reshaping
Digital Printing Solutions is being combined with EFI into a jointly held company, and the CEO said the group is always looking at strategic options while the cloud transition remains the first priority.

Latest results

In Q3 2026 continuing revenue was stable at 210 million euro, but adjusted EBITDA fell to 1 million euro (4 in Q3 2025) as savings and price increases did not fully offset lower volumes in film, Direct Radiography and green hydrogen; the net result was -24 million euro. Over nine months, revenue was 631 million euro (-2.5%) and adjusted EBITDA 25 million euro (+18%). HealthCare IT improved, with revenue up 11.2% and adjusted EBITDA of 5.5 million euro. Q3 free cash flow was -14 million euro after 16 million euro of transformation cash-outs, and net financial debt (excl. IFRS 16) rose to 92 million euro. For 2026 the company expects HealthCare IT profitability below last year because of the faster cloud shift, lower revenue and profitability in Imaging and Advanced Materials, and free cash flow more negative than 2025.

Investments and deals

DPS combination with EFI
Agreement signed on 28 September 2026 to combine Digital Printing Solutions with EFI, a Siris portfolio company; Siris will own 60% and Agfa 40%, with closing expected by end-2026.
New ZIRFON plant
A new ZIRFON membrane production facility opened in September 2025, backed by 11 million euro from the EU Innovation Fund, and a long-term innovation agreement was signed with VITO.
Film restructuring
Restructuring expenses were 54 million euro in 2025, including the Belgian plant reorganisation (29) and the closure of Bushy Park in the US (9); the programme affects 470 employees in Belgium in phase 1 and up to 145 more.
HealthCare IT R&D and AI
HealthCare IT spends close to EUR 40 million a year on R&D; AI is used in coding (30-50% productivity gains), diagnosis and workflow orchestration.

Challenges and risks

Declining medical film market
Radiology Solutions revenue fell 17.1% in 2025 as medical film declined, particularly in China, and a 28 million euro impairment was booked; film volumes kept falling in 2026.
Silver price volatility
Silver moved from $88 to $62 an ounce in 2026, adding 45 million euro of nine-month sales but costing just over 30 million euro of cash; it is managed through price indexation and leaner inventories.
Green hydrogen delays
ZIRFON revenue fell 82.2% in Q3 2026 after REDIII delays in Europe and new delays from the leaked RED IV proposal.
Cloud transition weighs on margins
The SaaS shift lowers short-term revenue and margins; the CEO said a SaaS contract catches up with a project contract after about four and a half years.
Debt, pensions and cash burn
Total debt was 450 million euro at Q3 2026, including net pension debt of 320 million euro, and free cash flow is expected to stay negative during the transformation.

What leadership says

“We are determined to make green hydrogen an industrial reality.”

Pascal Juéry, President and CEO · Agfa-Gevaert Annual Report 2025 (April 2026)

“Our savings initiatives and operational discipline are delivering tangible results, while the growing adoption of our cloud-based HealthCare IT solutions reinforces our confidence in the growth potential of the business.”

Pascal Juéry, President and CEO · H1 2026 results release (26 August 2026)

“We are one of the few players with a good track record of bringing Enterprise Imaging to the cloud.”

Pascal Juéry, President and CEO · Q3 2026 results conference call (10 November 2026)

“I still see the next couple of years to be transformation years, where we will have to spend still a significant amount in restructuring.”

Pascal Juéry, President and CEO · Q3 2026 results conference call (10 November 2026)

Where a supplier can help

Cloud migration and hosting for Enterprise Imaging
Tied to the HealthCare IT cloud and SaaS transition: suppliers of cloud infrastructure, migration services and managed operations can help convert the installed base and lower the cost to serve.
Cash and working-capital tools
Tied to the liquidity-first priority and silver-driven working capital: treasury, inventory planning (S&OP) and receivables financing offers fit a group that is already factoring and reviewing vendor financing.
Cost reduction in film operations
Tied to the self-funding film programme: automation, outsourcing and procurement services can support further savings in Mortsel operations as volumes decline.
Healthcare AI and workflow partners
Tied to HealthCare IT R&D and AI investment: third-party diagnostic and workflow applications can integrate with the cloud platform.
Green hydrogen project support
Tied to the expected 2027 ZIRFON rebound in China, India and Europe: logistics, local distribution and electrolyser-project partners can help capture demand as projects reach FID.

Tamtam's reading of the priorities and challenges above, not the company's own words.

Selling to companies like Agfa?

Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.

Find similar companies

Key documents

Read in full by Tamtam; each summary links to the document itself.

Questions about Agfa

What does Agfa-Gevaert do?

Agfa-Gevaert is a Belgian imaging-technology group. It sells enterprise imaging software to hospitals, X-ray film and digital radiography systems, specialty films and chemicals, and ZIRFON membranes for green hydrogen electrolysis.

What is Agfa-Gevaert's revenue?

FY2025 revenue was 1,086 million euro, down 4.5%, with adjusted EBITDA of 59 million euro and a net result of -71 million euro. Nine-month 2026 revenue from continuing operations was 631 million euro.

How many employees does Agfa-Gevaert have?

It had 4,211 employees in 2025, 69% of them in Europe and 16% in North America.

Who leads Agfa-Gevaert?

Pascal Juéry is CEO and Frank Aranzana chairs the board. Declan Guerin became CFO on 1 October 2026.

What is Agfa-Gevaert's strategy?

It is moving HealthCare IT to cloud and SaaS, shrinking its film cost base through a self-funding savings programme, betting on ZIRFON for green hydrogen, and combining Digital Printing Solutions with EFI.

Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)